750425
Last Update Posted: 2011-03-10
Recruiting has ended
All Genders accepted | 18 Years + |
46 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Phase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid Tumours
Phase I, open study to assess the effect of ketoconazole, a marketed drug, on the way the body handles the experimental drug cediranib, in patients with advanced cancer.
Eligibility
Relevant conditions:
Advanced Solid Tumors
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov